J. Virol., Jan 1996, 119-126, Vol 70, No. 1
Copyright © 1996, American Society for Microbiology

E2 represses the late gene promoter of human papillomavirus type 8 at high concentrations by interfering with cellular factors

F Stubenrauch, IM Leigh and H Pfister
Institut fur Klinische und Molekulare Virologie, Erlangen, Germany.

The late gene promoter P7535 of the epidermodysplasia verruciformis- associated human papillomavirus type 8 (HPV8) is regulated by the viral E2 protein. Transfection experiments performed with the human skin keratinocyte cell line RTS3b and P7535 reporter plasmids revealed transactivation at low amounts and a repression of basal promoter activity at high amounts of E2 expression vector. This repression was promoter specific and correlated with the amount of transiently expressed E2 protein. Mutational analyses revealed that the negative regulation of P7535 activity is mediated by the low-affinity E2 binding site P2, which is separated by one nucleotide from the P7535 TATA box. Biochemical and genetic analyses suggested that repression is due to a displacement of the TATA-box binding protein by E2 and an interference of E2 with promoter-activating cellular factors that specifically recognize the P2 sequence. The high conservation of the P2 sequence among several papillomaviruses (epidermodysplasia verruciformis- associated HPVs, HPV1, cottontail rabbit papillomavirus, and bovine papillomavirus type 1) in the vicinity of the late gene promoter cap site suggests that an interplay of E2 and cellular factors at this sequence element is important for the expression of structural proteins.

This article has been cited by other articles:

• Sanchez, I. E., Dellarole, M., Gaston, K., de Prat Gay, G. (2008). Comprehensive comparison of the interaction of the E2 master regulator with its cognate target DNA sites in 73 human papillomavirus types by sequence statistics. Nucleic Acids Res 36: 756-769 [Abstract] [Full Text]  
• Muller-Schiffmann, A., Beckmann, J., Steger, G. (2006). The e6 protein of the cutaneous human papillomavirus type 8 can stimulate the viral early and late promoters by distinct mechanisms.. J. Virol. 80: 8718-8728 [Abstract] [Full Text]  
• Hou, S. Y., Wu, S.-Y., Chiang, C.-M. (2002). Transcriptional Activity among High and Low Risk Human Papillomavirus E2 Proteins Correlates with E2 DNA Binding. J. Biol. Chem. 277: 45619-45629 [Abstract] [Full Text]  
• Muller, A., Ritzkowsky, A., Steger, G. (2002). Cooperative Activation of Human Papillomavirus Type 8 Gene Expression by the E2 Protein and the Cellular Coactivator p300. J. Virol. 76: 11042-11053 [Abstract] [Full Text]  
• Stubenrauch, F., Zobel, T., Iftner, T. (2001). The E8 Domain Confers a Novel Long-Distance Transcriptional Repression Activity on the E8^E2C Protein of High-Risk Human Papillomavirus Type 31. J. Virol. 75: 4139-4149 [Abstract] [Full Text]  
• Alloul, N., Sherman, L. (1999). Transcription-modulatory activities of differentially spliced cDNAs encoding the E2 protein of human papillomavirus type 16. J. Gen. Virol. 80: 2461-2470 [Abstract] [Full Text]  
• Lewis, H., Webster, K., Sanchez-Perez, A.-M., Gaston, K. (1999). Cellular transcription factors regulate human papillomavirus type 16 gene expression by binding to a subset of the DNA sequences recognized by the viral E2 protein. J. Gen. Virol. 80: 2087-2096 [Abstract] [Full Text]  
• Zhou, J., Liu, W. J., Peng, S. W., Sun, X. Y., Frazer, I. (1999). Papillomavirus Capsid Protein Expression Level Depends on the Match between Codon Usage and tRNA Availability. J. Virol. 73: 4972-4982 [Abstract] [Full Text]  
• Ozbun, M. A., Meyers, C. (1998). Temporal Usage of Multiple Promoters during the Life Cycle of Human Papillomavirus Type 31b. J. Virol. 72: 2715-2722 [Abstract] [Full Text]  
• Thain, A., Webster, K., Emery, D., Clarke, A. R., Gaston, K. (1997). DNA Binding and Bending by the Human Papillomavirus Type 16E2 Protein. RECOGNITION OF AN EXTENDED BINDING SITE. J. Biol. Chem. 272: 8236-8242 [Abstract] [Full Text]